Investment Analysts’ Recent Ratings Changes for EPAM Systems (EPAM)
A number of research firms have changed their ratings and price targets for EPAM Systems (NYSE: EPAM): 3/10/2025 – EPAM Systems had its price target lowered by analysts at Barclays PLC from $290.00 to $270.00. They now have an “overweight” rating on the stock. 2/24/2025 – EPAM Systems had its price target lowered by analysts […]
Investment Analysts’ Weekly Ratings Changes for Domo (DOMO)
Domo (NASDAQ: DOMO) recently received a number of ratings updates from brokerages and research firms: 3/13/2025 – Domo had its price target raised by analysts at Morgan Stanley from $7.00 to $9.00. They now have an “equal weight” rating on the stock. 3/10/2025 – Domo was upgraded by analysts at DA Davidson to a “hold” […]
Investment Analysts’ Recent Ratings Updates for Ferguson (FERG)
A number of firms have modified their ratings and price targets on shares of Ferguson (NASDAQ: FERG) recently: 3/12/2025 – Ferguson was given a new $190.00 price target on by analysts at Robert W. Baird. They now have an “outperform” rating on the stock. 3/12/2025 – Ferguson had its price target lowered by analysts at […]
Investment Analysts’ Recent Ratings Updates for Plug Power (PLUG)
Several brokerages have updated their recommendations and price targets on shares of Plug Power (NASDAQ: PLUG) in the last few weeks: 3/6/2025 – Plug Power had its price target lowered by analysts at Morgan Stanley from $1.75 to $1.60. They now have an “underweight” rating on the stock. 3/5/2025 – Plug Power had its price […]
Analysts’ Weekly Ratings Changes for Caesars Entertainment (CZR)
Caesars Entertainment (NASDAQ: CZR) recently received a number of ratings updates from brokerages and research firms: 3/6/2025 – Caesars Entertainment was upgraded by analysts at Susquehanna from a “negative” rating to a “neutral” rating. They now have a $30.00 price target on the stock. 2/26/2025 – Caesars Entertainment had its price target lowered by analysts […]
Recent Research Analysts’ Ratings Updates for Corbus Pharmaceuticals (CRBP)
Corbus Pharmaceuticals (NASDAQ: CRBP) has recently received a number of price target changes and ratings updates: 3/12/2025 – Corbus Pharmaceuticals had its “outperform” rating reaffirmed by analysts at Wedbush. They now have a $51.00 price target on the stock. 3/12/2025 – Corbus Pharmaceuticals had its “buy” rating reaffirmed by analysts at HC Wainwright. They now […]
last updated on 14 Mar 10:59